{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:27:25Z","timestamp":1778927245530,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","primarycare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pop.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T11:57:02Z","timestamp":1415102222000},"page":"803-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2, and the Kidneys"],"prefix":"10.1016","volume":"41","author":[{"given":"Saadur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Malcoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2014.09.001_bib1","first-page":"573","article-title":"The fight against rheumatism: from willow bark to COX-1 sparing drugs","volume":"51","author":"Vane","year":"2000","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.pop.2014.09.001_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"43","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.pop.2014.09.001_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0091-6749(76)90181-0","article-title":"The mode of action of aspirin and similar compounds","volume":"58","author":"Vane","year":"1976","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pop.2014.09.001_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/246217a0","article-title":"Prostaglandins, aspirin-like drugs and the oedema of inflammation","volume":"246","author":"Moncada","year":"1973","journal-title":"Nature"},{"issue":"Suppl 56","key":"10.1016\/j.pop.2014.09.001_bib5","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"26","author":"Singh","year":"1999","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pop.2014.09.001_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2215\/CJN.00890805","article-title":"Update on cyclo-oxygenase inhibitors","volume":"1","author":"Harris","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199717050-00001","article-title":"NSAIDs and increased blood pressure. What is the clinical significance?","volume":"17","author":"Johnson","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.pop.2014.09.001_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1370\/afm.1302","article-title":"Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States","volume":"9","author":"Plantinga","year":"2011","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.pop.2014.09.001_bib9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1345\/aph.1D296","article-title":"Nephrotoxic potential of selective cyclooxygenase-2 inhibitors","volume":"38","author":"Sandhu","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pop.2014.09.001_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pop.2014.09.001_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-7743(08)61087-8","article-title":"Prostanoid receptors","volume":"33","author":"Abramovitz","year":"1998","journal-title":"Annu Rep Med Chem"},{"key":"10.1016\/j.pop.2014.09.001_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2014.09.001_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(08)60430-7","article-title":"Prostaglandin endoperoxide H synthases-1 and -2","volume":"62","author":"Smith","year":"1996","journal-title":"Adv Immunol"},{"key":"10.1016\/j.pop.2014.09.001_bib14","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1073\/pnas.95.22.13313","article-title":"Pharmacological analysis of cyclooxygenase-1 in inflammation","volume":"95","author":"Smith","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pop.2014.09.001_bib15","first-page":"25943","article-title":"Selective expression of mitogen inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide","volume":"267","author":"Lee","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pop.2014.09.001_bib16","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","article-title":"Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain","volume":"91","author":"Seibert","year":"1994","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pop.2014.09.001_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase-2 deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pop.2014.09.001_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI5505","article-title":"Angiotensin II attenuates renal cortical cyclooxygenase-2 expression","volume":"103","author":"Cheng","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pop.2014.09.001_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903550208","article-title":"Characterization of inducible cyclooxygenase in rat brain","volume":"355","author":"Breder","year":"1995","journal-title":"J\u00a0Comp Neurol"},{"issue":"2","key":"10.1016\/j.pop.2014.09.001_bib20","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.pop.2014.09.001_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pop.2014.09.001_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF00858136","article-title":"Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam","volume":"8","author":"Voyer","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0028-2243(83)90108-9","article-title":"Indomethacin and the fetal renal nonfunction syndrome","volume":"16","author":"Veersema","year":"1983","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.pop.2014.09.001_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0272-6386(12)80215-0","article-title":"Ketorolac-induced acute renal failure and hyperkalemia: report of three cases","volume":"24","author":"Haragsim","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.pop.2014.09.001_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198809153191106","article-title":"Clinical implications of prostaglandin and thromboxane A2 formation","volume":"319","author":"Oates","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pop.2014.09.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","article-title":"The clinical significance of inhibition of renal prostaglandin synthesis","volume":"32","author":"Patrono","year":"1987","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.pop.2014.09.001_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14740338.1.1.53","article-title":"COX-2 selective inhibitors: analysis of the renal effects","volume":"1","author":"Perazella","year":"2002","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.pop.2014.09.001_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9343(01)00757-4","article-title":"Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs","volume":"111","author":"Perazella","year":"2001","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.pop.2014.09.001_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwj331","article-title":"Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis","volume":"164","author":"Schneider","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.pop.2014.09.001_bib30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","article-title":"Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population","volume":"45","author":"Huerta","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pop.2014.09.001_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000413415","article-title":"Pathophysiology and clinical aspects of drug-induced tubular necrosis in man","volume":"55","author":"Kleinknecht","year":"1987","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib32","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pop.2014.09.001_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ki.1991.255","article-title":"Early renal medullary hypoxic injury from radiocontrast and indomethacin","volume":"40","author":"Heyman","year":"1991","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.pop.2014.09.001_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pop.2014.09.001_bib35","first-page":"179","article-title":"The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis","volume":"54","author":"Schwarz","year":"2000","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.pop.2014.09.001_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5414\/CNP63385","article-title":"COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature","volume":"63","author":"Esteve","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.pop.2014.09.001_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.pop.2014.09.001_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute tubulointerstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.pop.2014.09.001_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.ki.5002776","article-title":"Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis","volume":"73","author":"Gonzales","year":"2008","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.pop.2014.09.001_bib42","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","article-title":"Acute interstitial nephritis: clinical features and response to corticosteroid therapy","volume":"19","author":"Clarkson","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.pop.2014.09.001_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2215\/CJN.01711105","article-title":"Mycophenolate mofetil for the treatment of interstitial nephritis","volume":"1","author":"Preddle","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2014.09.001_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CNP64155","article-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment","volume":"64","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2014.09.001_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0272-6386(12)70328-1","article-title":"Ranitidine-induced acute interstitial nephritis with epithelial cell foot process fusion","volume":"22","author":"Gaughan","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pop.2014.09.001_bib46","first-page":"55","article-title":"Patterns of tubulo-interstitial damage associated with nonsteroidal antiinflammatory drugs","volume":"8","author":"Levin","year":"1988","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib47","first-page":"228","article-title":"Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs","volume":"15","author":"Kleinknecht","year":"1995","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000166764","article-title":"Glomerular and interstitial disease induced by nonsteroidal anti- inflammatory drugs","volume":"4","author":"Abraham","year":"1984","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib49","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/ajkd.2002.36349","article-title":"Nephrotic syndrome and interstitial nephritis associated with celecoxib","volume":"40","author":"Alper","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.pop.2014.09.001_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0272-6386(89)80130-1","article-title":"Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs","volume":"13","author":"Warren","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.pop.2014.09.001_bib51","first-page":"143","article-title":"Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults","volume":"55","author":"Matsumoto","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pop.2014.09.001_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00045391-199701000-00011","article-title":"Acute renal papillary necrosis induced by ibuprofen","volume":"4","author":"Atta","year":"1997","journal-title":"Am J Ther"},{"key":"10.1016\/j.pop.2014.09.001_bib53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJM199802123380707","article-title":"Analgesic nephropathy","volume":"338","author":"DeBroe","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2014.09.001_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0272-6386(12)80155-7","article-title":"Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic","volume":"24","author":"Segasothy","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pop.2014.09.001_bib55","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1093\/ndt\/gfl390","article-title":"Obituary to analgesic nephropathy\u2014an autopsy study","volume":"21","author":"Mihatsch","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pop.2014.09.001_bib56","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI9956","article-title":"Dehydration activates an NF-\u03ba B-driven, COX2-dependent survival mechanism in renal medullary interstitial cells","volume":"106","author":"Hao","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.pop.2014.09.001_bib57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.ki.5002251","article-title":"Analgesic nephropathy","volume":"72","author":"Vadivel","year":"2007","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.pop.2014.09.001_bib58","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ndt\/gfg230","article-title":"Analgesic-associated nephropathy in the West of Scotland: a 12-year observational study","volume":"18","author":"Mackinnon","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.pop.2014.09.001_bib59","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1981.89","article-title":"Role of prostaglandins in the regulation of renal water excretion","volume":"19","author":"Kramer","year":"1981","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.pop.2014.09.001_bib60","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.V541106","article-title":"Increased susceptibility to thiazide-induced hyponatremia in the elderly","volume":"5","author":"Clark","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.pop.2014.09.001_bib61","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.1993.293","article-title":"Renal complications of nonsteroidal anti-inflammatory drugs","volume":"44","author":"Schlondorff","year":"1993","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.pop.2014.09.001_bib62","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI109615","article-title":"Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors","volume":"64","author":"Campbell","year":"1979","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.pop.2014.09.001_bib63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5694\/j.1326-5377.2011.tb02982.x","article-title":"Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis","volume":"194","author":"Ng","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.pop.2014.09.001_bib64","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1097\/01.ASN.0000023430.92674.E5","article-title":"Renal tubular acidosis: the clinical entity","volume":"13","author":"Soriano","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6488","key":"10.1016\/j.pop.2014.09.001_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmj.291.6488.107","article-title":"Incidence of hyperkalaemia induced by indomethacin in a hospital population","volume":"291","author":"Zimran","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.pop.2014.09.001_bib66","series-title":"Acid-base and electrolyte disorders: a companion to Brenner and Rector\u2019s the kidney","first-page":"189","article-title":"Renal tubular acidosis","author":"DuBose","year":"2002"},{"key":"10.1016\/j.pop.2014.09.001_bib67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.HYP.0000258106.74139.25","article-title":"Cardiovascular effects of the cyclooxygenase inhibitors","volume":"49","author":"White","year":"2007","journal-title":"Hypertension"},{"issue":"Suppl B","key":"10.1016\/j.pop.2014.09.001_bib68","doi-asserted-by":"crossref","first-page":"B27","DOI":"10.1093\/eurheartj\/sur009","article-title":"Physiology of aldosterone and pharmacology of aldosterone blockers","volume":"13","author":"Struthers","year":"2011","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.pop.2014.09.001_bib69","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.HYP.0000115921.55353.e0","article-title":"Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and Hispanics","volume":"43","author":"Izhar","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pop.2014.09.001_bib70","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9149(02)02661-9","article-title":"Effects of celecoxib and rofecoxib on blood pressure and edema in patients\u00a0>65 years of age with systemic hypertension and osteoarthritis","volume":"90","author":"Whelton","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pop.2014.09.001_bib71","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archinte.1995.00430100075009","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil","volume":"155","author":"Houston","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pop.2014.09.001_bib72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0895-7061(94)00164-7","article-title":"Assessment of blood pressure during naproxen therapy in\u00a0hypertensive patients treated with nicardipine","volume":"8","author":"Klassen","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pop.2014.09.001_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.165.2.161","article-title":"The effects of cyclooxygenase-2 inhibitors and nonsteroidal antiinflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis and type 2 diabetes","volume":"165","author":"Sowers","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pop.2014.09.001_bib74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"Johnson","year":"1994","journal-title":"Ann Intern Med"},{"issue":"363","key":"10.1016\/j.pop.2014.09.001_bib75","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high CV risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"19","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2014.09.001_bib76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)17864-7","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"Graham","year":"2005","journal-title":"Lancet"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454314000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454314000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T04:51:21Z","timestamp":1650516681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454314000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0095454314000979"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2014.09.001","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2, and the Kidneys","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}